Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 10/20 | 0.41 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.40 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.38 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31428538 | 0.91 | HPGD (0.46) | ALDH1A1SMN1; SMN2MAPTMAPK1HTT | |
| Hydrochloric Acid SCHEMBL31428503 | 0.90 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2MAPTMAPK1HTT | |
| SCHEMBL31428440 | 0.90 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2MAPTMAPK1HTT | |
| SCHEMBL30163546 | 0.89 | MAPT (0.41) | ALDH1A1SMN1; SMN2MAPTMAPK1HTT | |
| SCHEMBL30163505 | 0.88 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2MAPTMAPK1HTT | |
| SCHEMBL30163507 | 0.87 | MAPK1 (0.40) | ALDH1A1SMN1; SMN2MAPTMAPK1HTT | |
| SCHEMBL31428674 | 0.87 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2MAPTMAPK1HTT | |
| SCHEMBL31428623 | 0.86 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2MAPTMAPK1HTT | |
| SCHEMBL31428867 | 0.86 | PKM (0.44) | ALDH1A1SMN1; SMN2MAPTMAPK1HTT | |
| SCHEMBL31428528 | 0.86 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2MAPTMAPK1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250091994-A1 | RAS/RAF BINDING INHIBITOR COMPOUND | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2025-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250091994-A1 | RAS/RAF BINDING INHIBITOR COMPOUND | BRAF, RAF1, NRAS | ALDH1A1 2352/4885SMN1; SMN2 4832/4885MAPT 4513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.